|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Stem Cell Niche |
1 INSERM U790, Institut Gustave Roussy, PR1, Villejuif, France
* To whom correspondence should be addressed. E-mail: fawl{at}igr.fr.
| Abstract |
|---|
As an intracellular second messenger, nitric oxide (NO) is increasingly implicated in the control of the transcriptional machinery and gene expression. Here, we show that cell surface expression of CXCR4 on CD34+ cells was increased in a dose and time dependent manner in response to NO donors. Augmented surface expression was correlated with an increased in CXCR4 mRNA level. A specific NO scavenger prevented the elevation in CXCR4 mRNA caused by NO donors suggesting a direct signaling action mediated by NO on CXCR4 transcription. NO treatment had no significant effect on CXCR4 mRNA stability. However, induction of CXCR4 mRNA by NO was still observed in conditions where initiation of translation was inhibited suggesting that the NO effect must be mediated by a pre-existing protein. CXCR4 mRNA induction did not involve guanosine 3', 5'-cyclic monophosphate (cGMP) generation, but was most likely mediated via oxidation of intracellular protein thiols. Finally, CD34+ cells pre-treated with NO donors exhibited an increased chemotactic response. This study demonstrates that the NO pathway can modulate CXCR4 expression in human CD34+ cells and suggests that NO may play a critical role in the trafficking of hematopoietic progenitors.
Key Words. nitric oxide, CXCR4, SDF-1, gene expression, CD34+ cells
This article has been cited by other articles:
![]() |
L. Lordier, A. Jalil, F. Aurade, F. Larbret, J. Larghero, N. Debili, W. Vainchenker, and Y. Chang Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling Blood, October 15, 2008; 112(8): 3164 - 3174. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Focosi, R. E. Kast, S. Galimberti, and M. Petrini Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex J. Leukoc. Biol., August 1, 2008; 84(2): 331 - 337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
